Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE
Condition: Hepatocellular Carcinoma Intervention: Drug: Lumason Sponsors: Milton S. Hershey Medical Center; Penn State Health Liver Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research | Ultrasound